학술논문

Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial
Document Type
Article
Source
In Immuno-Oncology and Technology June 2024 22
Subject
Language
ISSN
2590-0188